{
    "info": {
        "nct_id": "NCT03596645",
        "official_title": "A Phase 3 Randomized, Open-Label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Golimumab Treatment, a Human Anti-TNFÎ± Monoclonal Antibody, Administered Subcutaneously in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis",
        "inclusion_criteria": "* Must either be currently receiving treatment with, or have a history of having failed to respond to, or have a medical contraindication to at least 1 of the following therapies: oral or intravenous corticosteroids, 6-mercaptopurine, methotrexate or azathioprine OR must either have or have had a history of corticosteroid dependency (that is an inability to successfully taper corticosteroids without a return of the symptoms of ulcerative colitis [UC]) OR required more than 3 courses of corticosteroids in the past year\n* Moderately to severely active UC (as defined by baseline Mayo score of 6 through 12 [endoscopy {sigmoidoscopy or colonoscopy} sub score assigned by local endoscopist], inclusive), including a (sigmoidoscopy or colonoscopy) sub score greater than or equal to (>=2)\n* If receiving enteral nutrition, must have been on a stable regimen for at least 2 weeks prior to the first administration of study intervention at Week 0. Participants who receive parenteral nutrition are not permitted to enroll in the trial\n* No history of latent or active tuberculosis prior to screening\n* Must be up to date with all immunizations (that is, measles, mumps, rubella, and varicella) in agreement with current local immunization guidelines for immunosuppressed participants before Week 0\nHealthy volunteers allowed\nMust have minimum age of 2 Years\nMust have maximum age of 17 Years",
        "exclusion_criteria": "* History of liver or renal insufficiency; significant cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematologic, rheumatologic, psychiatric (including suicidality), or metabolic disturbances\n* History of malignancy or macrophage activation syndrome or hemophagocytic lymphohistiocytosis\n* Have UC limited to the rectum only or to <20 percent (%) of the colon\n* Presence of a stoma\n* Presence or history of a fistula\n* Contraindications to the use of golimumab or infliximab or anti-tumor necrosis factor (TNF-alpha) therapy per local prescribing information",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Must either be currently receiving treatment with, or have a history of having failed to respond to, or have a medical contraindication to at least 1 of the following therapies: oral or intravenous corticosteroids, 6-mercaptopurine, methotrexate or azathioprine OR must either have or have had a history of corticosteroid dependency (that is an inability to successfully taper corticosteroids without a return of the symptoms of ulcerative colitis [UC]) OR required more than 3 courses of corticosteroids in the past year",
            "criterions": [
                {
                    "exact_snippets": "currently receiving treatment with ... at least 1 of the following therapies: oral or intravenous corticosteroids, 6-mercaptopurine, methotrexate or azathioprine",
                    "criterion": "treatment with specified therapies",
                    "requirements": [
                        {
                            "requirement_type": "current treatment",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "therapy type",
                            "expected_value": [
                                "oral corticosteroids",
                                "intravenous corticosteroids",
                                "6-mercaptopurine",
                                "methotrexate",
                                "azathioprine"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "history of having failed to respond to ... at least 1 of the following therapies: oral or intravenous corticosteroids, 6-mercaptopurine, methotrexate or azathioprine",
                    "criterion": "response to specified therapies",
                    "requirements": [
                        {
                            "requirement_type": "history of failed response",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "therapy type",
                            "expected_value": [
                                "oral corticosteroids",
                                "intravenous corticosteroids",
                                "6-mercaptopurine",
                                "methotrexate",
                                "azathioprine"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "medical contraindication to at least 1 of the following therapies: oral or intravenous corticosteroids, 6-mercaptopurine, methotrexate or azathioprine",
                    "criterion": "medical contraindication to specified therapies",
                    "requirements": [
                        {
                            "requirement_type": "medical contraindication",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "therapy type",
                            "expected_value": [
                                "oral corticosteroids",
                                "intravenous corticosteroids",
                                "6-mercaptopurine",
                                "methotrexate",
                                "azathioprine"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "have or have had a history of corticosteroid dependency (that is an inability to successfully taper corticosteroids without a return of the symptoms of ulcerative colitis [UC])",
                    "criterion": "corticosteroid dependency",
                    "requirements": [
                        {
                            "requirement_type": "history of dependency",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "required more than 3 courses of corticosteroids in the past year",
                    "criterion": "courses of corticosteroids in the past year",
                    "requirements": [
                        {
                            "requirement_type": "number of courses",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "courses"
                            }
                        },
                        {
                            "requirement_type": "time period",
                            "expected_value": "past year"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* If receiving enteral nutrition, must have been on a stable regimen for at least 2 weeks prior to the first administration of study intervention at Week 0. Participants who receive parenteral nutrition are not permitted to enroll in the trial",
            "criterions": [
                {
                    "exact_snippets": "If receiving enteral nutrition, must have been on a stable regimen for at least 2 weeks prior to the first administration of study intervention at Week 0",
                    "criterion": "enteral nutrition regimen",
                    "requirements": [
                        {
                            "requirement_type": "stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Participants who receive parenteral nutrition are not permitted to enroll in the trial",
                    "criterion": "parenteral nutrition",
                    "requirements": [
                        {
                            "requirement_type": "absence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Moderately to severely active UC (as defined by baseline Mayo score of 6 through 12 [endoscopy {sigmoidoscopy or colonoscopy} sub score assigned by local endoscopist], inclusive), including a (sigmoidoscopy or colonoscopy) sub score greater than or equal to (>=2)",
            "criterions": [
                {
                    "exact_snippets": "Moderately to severely active UC",
                    "criterion": "ulcerative colitis disease activity",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": [
                                "moderate",
                                "severe"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "baseline Mayo score of 6 through 12 ... inclusive",
                    "criterion": "Mayo score",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 6,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 12,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "(sigmoidoscopy or colonoscopy) sub score greater than or equal to (>=2)",
                    "criterion": "sigmoidoscopy or colonoscopy sub score",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": ""
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* No history of latent or active tuberculosis prior to screening",
            "criterions": [
                {
                    "exact_snippets": "No history of latent or active tuberculosis prior to screening",
                    "criterion": "tuberculosis history",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "latent",
                                "active"
                            ]
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": "prior to screening"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must be up to date with all immunizations (that is, measles, mumps, rubella, and varicella) in agreement with current local immunization guidelines for immunosuppressed participants before Week 0",
            "criterions": [
                {
                    "exact_snippets": "Must be up to date with all immunizations (that is, measles, mumps, rubella, and varicella) in agreement with current local immunization guidelines for immunosuppressed participants before Week 0",
                    "criterion": "immunizations (measles, mumps, rubella, varicella)",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "up to date"
                        },
                        {
                            "requirement_type": "compliance",
                            "expected_value": "in agreement with current local immunization guidelines for immunosuppressed participants"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "before Week 0"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 2 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 2 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 17 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 17 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 17,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Presence or history of a fistula",
            "criterions": [
                {
                    "exact_snippets": "Presence or history of a fistula",
                    "criterion": "fistula",
                    "requirements": [
                        {
                            "requirement_type": "presence or history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Presence of a stoma",
            "criterions": [
                {
                    "exact_snippets": "Presence of a stoma",
                    "criterion": "stoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of malignancy or macrophage activation syndrome or hemophagocytic lymphohistiocytosis",
            "criterions": [
                {
                    "exact_snippets": "History of malignancy",
                    "criterion": "malignancy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "macrophage activation syndrome",
                    "criterion": "macrophage activation syndrome",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hemophagocytic lymphohistiocytosis",
                    "criterion": "hemophagocytic lymphohistiocytosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Contraindications to the use of golimumab or infliximab or anti-tumor necrosis factor (TNF-alpha) therapy per local prescribing information",
            "criterions": [
                {
                    "exact_snippets": "Contraindications to the use of golimumab",
                    "criterion": "contraindications to golimumab",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Contraindications to the use of ... infliximab",
                    "criterion": "contraindications to infliximab",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Contraindications to the use of ... anti-tumor necrosis factor (TNF-alpha) therapy per local prescribing information",
                    "criterion": "contraindications to anti-tumor necrosis factor (TNF-alpha) therapy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of liver or renal insufficiency; significant cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematologic, rheumatologic, psychiatric (including suicidality), or metabolic disturbances",
            "criterions": [
                {
                    "exact_snippets": "History of liver or renal insufficiency",
                    "criterion": "liver insufficiency",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of liver or renal insufficiency",
                    "criterion": "renal insufficiency",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "significant cardiac ... disturbances",
                    "criterion": "cardiac disturbances",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "significant ... vascular ... disturbances",
                    "criterion": "vascular disturbances",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "significant ... pulmonary ... disturbances",
                    "criterion": "pulmonary disturbances",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "significant ... gastrointestinal ... disturbances",
                    "criterion": "gastrointestinal disturbances",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "significant ... endocrine ... disturbances",
                    "criterion": "endocrine disturbances",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "significant ... neurologic ... disturbances",
                    "criterion": "neurologic disturbances",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "significant ... hematologic ... disturbances",
                    "criterion": "hematologic disturbances",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "significant ... rheumatologic ... disturbances",
                    "criterion": "rheumatologic disturbances",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "significant ... psychiatric (including suicidality) ... disturbances",
                    "criterion": "psychiatric disturbances",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "significant ... psychiatric (including suicidality) ... disturbances",
                    "criterion": "suicidality",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "significant ... metabolic disturbances",
                    "criterion": "metabolic disturbances",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have UC limited to the rectum only or to <20 percent (%) of the colon",
            "criterions": [
                {
                    "exact_snippets": "UC limited to the rectum only",
                    "criterion": "ulcerative colitis (UC) location",
                    "requirements": [
                        {
                            "requirement_type": "anatomic extent",
                            "expected_value": "rectum only"
                        }
                    ]
                },
                {
                    "exact_snippets": "UC limited ... to <20 percent (%) of the colon",
                    "criterion": "ulcerative colitis (UC) location",
                    "requirements": [
                        {
                            "requirement_type": "anatomic extent",
                            "expected_value": {
                                "operator": "<",
                                "value": 20,
                                "unit": "percent of the colon"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}